US Patent Issued to Dana-Farber Cancer Institute, Board of Regents of the University of Texas System on July 22 for "Small molecule inhibitors of SRC tyrosine kinase" (Massachusetts, Texas Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,664, issued on July 22, was assigned to Dana-Farber Cancer Institute Inc. (Boston) and Board of Regents of the University of Texas System (Austin, Texas).

"Small molecule inhibitors of SRC tyrosine kinase" was invented by Nathanael S. Gray (Boston), Guangyan Du (Boston), Tinghu Zhang (Brookline, Mass.), Nathaniel Henning (Brookline, Mass.), Suman Rao (Boston), Kenneth Westover (Austin, Texas) and Deepak Gurbani (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof. Also disclosed herein are methods of using the compounds of Formula (I) in the treatmen...